|Articles|March 17, 2023
News Roundup: March 13 to March 17
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
Novo Nordisk To Cut Insulin Prices Up To 75%
According to a company press release, the price reductions will go into effect at the start of 2024.
US District Judge Hearing Arguments to Potentially Halt Distribution of Abortion Pill Mifepristone
The decision could potentially limit abortion access for people all around the United States.
FDA Authorizes Bivalent Pfizer-BioNTech COVID-19 Vaccine As Booster Dose For Young Children
A new booster shot of the Pfizer-BioNTech COVID-19 vaccine is now available for children aged 6 months to 4 years, in an effort to continue to curb the effects of COVID-19.
FDA Grants De Novo Approval to Non-Invasive Tinnitus Treatment Device
The product, called Lenire, uses bimodal stimulation and will be available in April 2023.
Nasal Spray For Migraines Gets FDA Approval
The spray, called Zavzpret, intends to help individuals who struggle with migraines but can't take oral medication because of nausea or vomiting.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Metformin Cuts Long COVID Risk by Half in New ACTIV-6 Trial Results
2
FDA Committee Votes Unanimously to Recommend mRNA Flu Vaccine
3
Tyson Drug Company: Med Sync and Adherence Are Their Formula for Success
4
How Will Emerging AI Impact the Pharmacy Benefit Manager Space?
5